Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 18,172 shares at $30.03 ($547K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Scheduled sale ($547k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.03 | 8,636 | $259K | 47.4% |
| 2 | $30.03 | 8,636 | $259K | 47.4% |
| 3 | $31.13 | 900 | $28K | 5.1% |
| Total | $30.08 avg | 18,172 | $547K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $141K | — | Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $119K | — | Filing → |